MOOCs 2.0: Reviewing n.paradoxa's MOOC on Contemporary Art and Feminism

This collaboratively written article explores the pedagogical role of MOOCs today through analysis of a MOOC on contemporary art and feminism, created by Katy Deepwell, editor of the international feminist art journal n.paradoxa. Parme Giuntini offers an updated overview of MOOCs and their increasing value as OERs for faculty and students. Feminist art historians Anne Swartz and Kathleen Wentrack investigate the n.paradoxa MOOC from different, but complimentary perspectives. Wentrack explores the structure, documents, and interactivity of the MOOC as a rich source of feminist material useful to both students and scholars. Swartz addresses Deepwell’s international treatment of transnational feminism at a moment when feminIsm is under worldwide siege

Bridging the Research/Teaching Divide with DAH and SoTL-AH

This paper explores the potential for rigorous pedagogical scholarship to complement developments in digital art history (DAH). In addition to introducing ideas and methods that characterize scholarship of teaching and learning (SOTL) in higher education, we focus on two major themes: how digital tools and techniques can support robust scholarship of teaching and learning in art history (SoTL-AH) and ways that SoTL-AH can be used to evaluate and demonstrate the impact of DAH projects in the classroom and the public realm. Our goal is to encourage greater exchange between these two emerging fields that can together advance art historical study

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Digital Tools and Physical Objects: Connecting Museums, Teaching, and Scholarship through Art History Teaching Resources

This presentation will highlight specific entries on the AHTR Weekly blog and in our lesson plan project that have bridged the divide between academic art history, museums, and K-12 classrooms. These include entries on the AHTR Weekly concerning one of the largest Art + Feminism Wikipedia Edit-a-thons in the country and how the same principles were applied in a classroom, the differences between mentoring for those teaching in museums and those teaching in the university, the connections between lesson plans about the Near East and Islam and contemporary violence committed by ISIS, and the suggestions made by the College Board to revitalize AP art history and how they can be applied to higher education. We will end by discussing how the relationship between AHTR and its recently launched online open access journal, Art History Pedagogy and Practice, can serve as a means of connecting museum education, teaching, and scholarship further by offering a means by which the majority of academic labor, as seen through the lens of the scholarship of teaching and learning (SoTL), can be taken seriously in university systems and beyond